Biznes i nauka razem.

Innowacje dla zdrowia i jakości życia.

ADCITMER, an optimized antibody-drug conjugate to solve Merkel Cell carcinoma unmet...

Introduction - the problem:Merkel cell carcinoma (MCC) is a rare and agressive skin cancer with a 5-year overall survival of 40%. Patients are first...

New technologies for clinical trials: eCRF secured by blockchain

Introduction - the problem:Nowadays clinical trials are mostly held in paper form. There is no trend of using applications thats supports the CRF in...